Welch Allyn’s new PanOptic Ophthalmoscope features patented optical technology that gives health care professionals a wider, more panoramic view of the retina – or fundus – of the eye.
Featuring an optical design called Axial PointSource Optics, the PanOptic Ophthalmoscope provides a 25° field-of-view, making it possible to see the different features of the fundus more efficiently than the standard scope’s 5° field-of-view.
The patented Axial PointSource Optics work by converging the halogen illumination to a point at the cornea, allowing easy entry into even the smallest pupils. It then enables the illumination pathway to diverge to the retina, creating a wide illuminated area of the fundus.
Simultaneously, the unique viewing system allows the operator to view the illuminated area on virtually the same axis, delivering the widest field-of-view attainable with an ophthalmoscope in an undilated eye.
The design also creates a greater working distance between the practitioner and the patient, greatly improving the comfort level of both during the exam, while at the same time delivering a 26% increase in magnification to make it easier to see retinal details.
Ophthalmoscopy has been performed by a wide range of practitioners from generalists to specialists since Welch Allyn developed the world’s first hand-held, direct illuminating ophthalmoscope in 1915.
The funduscopic exam is unique in its ability to enable non-invasive visualisation of the vascular system in its natural state.
Systemic diseases such as diabetes and hypertension, which leave ‘foot-prints’ in the retina, as well as numerous ocular disorders can be detected and followed with an ophthalmoscope.